Author

Lirui Song

Scripps Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1

Frequent Co-Authors

Alireza Rahimi· 2 shared Amal Gebara-LambiD· 2 shared Anil K. Sen GuptaiD· 2 shared Armen Nazarian· 2 shared Arnab K. ChatterjeeiD· 2 shared Ashley K. Woods· 2 shared Case W. McNamaraiD· 2 shared Edward HuangiD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Alireza Rahimi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologyVirusesPeer-reviewedJul 26, 2026

Orally Bioavailable SARS-CoV-2 Protease Inhibitors Bearing a Hydroxymethyl Ketone Warhead

N. G. R. Dayan Elshan, Karen C. Wolff, Frank O. Weiss…·Arnab K. Chatterjee

This paper describes the development of orally bioavailable SARS-CoV-2 protease inhibitors with a hydroxymethyl ketone warhead, showing improved potency and bioavailability compared to previous compounds.

1 citationtop 5%

experimental assaydrug response / drug discovery

𝕏 PostBluesky

MicrobiologyJournal of Medicinal ChemistryPeer-reviewedFeb 9, 2024

Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Covalent Warhead

N. G. R. Dayan Elshan, Karen C. Wolff, Laura Riva…·Arnab K. Chatterjee

This paper introduces CMX990, a potent SARS-CoV-2 3CL protease inhibitor with improved potency and clearance compared to nirmatrelvir, advancing to Phase 1 clinical trials.

25 citationstop 2%

humanexperimental assay

𝕏 PostBluesky